These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 38882456)

  • 1. EBV-Related Lymphoproliferative Diseases: A Review in Light of New Classifications.
    Tralongo P; Bakacs A; Larocca LM
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024042. PubMed ID: 38882456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.
    Kim HJ; Ko YH; Kim JE; Lee SS; Lee H; Park G; Paik JH; Cha HJ; Choi YD; Han JH; Huh J;
    J Pathol Transl Med; 2017 Jul; 51(4):352-358. PubMed ID: 28592786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Advances in EBV Related Lymphoproliferative Diseases.
    Lv K; Yin T; Yu M; Chen Z; Zhou Y; Li F
    Front Oncol; 2022; 12():838817. PubMed ID: 35515118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases.
    Zhang P; Zeng C; Cheng J; Zhou J; Gu J; Mao X; Zhang W; Cao Y; Luo H; Xu B; Li Q; Xiao M; Zhou J
    Open Forum Infect Dis; 2019 May; 6(5):ofz171. PubMed ID: 31065564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.
    Neparidze N; Lacy J
    Clin Adv Hematol Oncol; 2014 Jun; 12(6):358-71. PubMed ID: 25003566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ hybridisation for Epstein-Barr virus as a differential diagnostic tool for T- and natural killer/T-cell lymphomas in non-immunocompromised patients.
    Chuang SS
    Pathology; 2014 Dec; 46(7):581-91. PubMed ID: 25393247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
    Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
    BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-associated lymphoproliferative disorders: classification and treatment.
    Carbone A; Gloghini A; Dotti G
    Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.
    Kim WY; Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
    Front Pediatr; 2019; 7():71. PubMed ID: 30931288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced PD-L1 Expression in LMP1-positive Cells of Epstein-Barr Virus-associated Malignant Lymphomas and Lymphoproliferative Disorders: A Single-cell Resolution Analysis With Multiplex Fluorescence Immunohistochemistry and In Situ Hybridization.
    Kume A; Shinozaki-Ushiku A; Kunita A; Kondo A; Ushiku T
    Am J Surg Pathol; 2022 Oct; 46(10):1386-1396. PubMed ID: 35605962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related EBV-associated B-cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: New insights into immune escape and immunodeficiency through staining with anti-PD-L1 antibody clone SP142.
    Sakakibara A; Kohno K; Ishikawa E; Suzuki Y; Shimada S; Eladl AE; Elsayed AA; Daroontum T; Satou A; Takahara T; Ohashi A; Takahashi E; Kato S; Nakamura S; Asano N
    Pathol Int; 2020 Aug; 70(8):481-492. PubMed ID: 32367595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and management of EBV-positive lymphoproliferative disorders].
    Arai A
    Rinsho Ketsueki; 2023; 64(8):764-771. PubMed ID: 37673629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases.
    Kimura H; Fujiwara S
    Front Pediatr; 2018; 6():417. PubMed ID: 30662890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV-positive B-cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency.
    Satou A; Nakamura S
    Cancer Med; 2021 Oct; 10(19):6777-6785. PubMed ID: 34387382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders: A Review and New Paradigm.
    Chapman J
    Surg Pathol Clin; 2023 Jun; 16(2):213-231. PubMed ID: 37149357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.
    Dojcinov SD; Fend F; Quintanilla-Martinez L
    Pathogens; 2018 Mar; 7(1):. PubMed ID: 29518976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases.
    Hui KF; Yiu SPT; Tam KP; Chiang AKS
    Front Oncol; 2019; 9():81. PubMed ID: 30873380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.
    Shimoyama Y; Oyama T; Asano N; Oshiro A; Suzuki R; Kagami Y; Morishima Y; Nakamura S
    J Clin Exp Hematop; 2006 Mar; 46(1):1-4. PubMed ID: 17058802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epstein-Barr virus infection and lymphoproliferative disorders].
    Isobe Y
    Rinsho Ketsueki; 2020; 61(9):1286-1296. PubMed ID: 33162528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.